MedPath

AG-LETROZOLE

AG-LETROZOLE

Approved
DIN Number

02374439

Drug Class

Human

Market Date

Feb 3, 2022

Company
HC

angita pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02374439
AIG Number0132937001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BG04 LETROZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LETROZOLEActive
Strength: 2.5 MG
Monograph: LETROZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.